TMV.DETMV.DEXETRA
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR+19.9%
5Y CAGR-2.2%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
+19.9%/yr
vs -25.8%/yr prior
5Y CAGR
-2.2%/yr
Recent acceleration
Acceleration
+45.7pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202520.53%
2024-0.23%
202315.24%
202211.91%
202133.26%
202022.92%
201964.65%
201839.28%
201727.05%
20160.00%